BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of 25.20 billion. The enterprise value is 23.68 billion.
| Market Cap | 25.20B |
| Enterprise Value | 23.68B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.29B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | +4.62% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 69.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 74.17 |
| PS Ratio | 6.04 |
| PB Ratio | 7.20 |
| P/TBV Ratio | 7.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 118.87 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -60.36 |
| EV / Sales | 5.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -131.24 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.96 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.52 |
| Interest Coverage | -15.99 |
Financial Efficiency
Return on equity (ROE) is -11.44% and return on invested capital (ROIC) is -4.16%.
| Return on Equity (ROE) | -11.44% |
| Return on Assets (ROA) | -3.22% |
| Return on Invested Capital (ROIC) | -4.16% |
| Return on Capital Employed (ROCE) | -7.69% |
| Revenue Per Employee | 379,624 |
| Profits Per Employee | -35,670 |
| Employee Count | 11,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.62% in the last 52 weeks. The beta is 0.49, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +11.62% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.61 |
| Average Volume (20 Days) | 499 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, BeiGene had revenue of 4.18 billion and -392.37 million in losses. Loss per share was -3.70.
| Revenue | 4.18B |
| Gross Profit | 3.54B |
| Operating Income | -296.56M |
| Pretax Income | -268.68M |
| Net Income | -392.37M |
| EBITDA | -122.01M |
| EBIT | -296.56M |
| Loss Per Share | -3.70 |
Balance Sheet
The company has 2.52 billion in cash and 996.83 million in debt, giving a net cash position of 1.52 billion.
| Cash & Cash Equivalents | 2.52B |
| Total Debt | 996.83M |
| Net Cash | 1.52B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.50B |
| Book Value Per Share | 32.42 |
| Working Capital | 1.91B |
Cash Flow
In the last 12 months, operating cash flow was 212.02 million and capital expenditures -392.49 million, giving a free cash flow of -180.47 million.
| Operating Cash Flow | 212.02M |
| Capital Expenditures | -392.49M |
| Free Cash Flow | -180.47M |
| FCF Per Share | n/a |
Margins
Gross margin is 84.81%, with operating and profit margins of -7.10% and -9.40%.
| Gross Margin | 84.81% |
| Operating Margin | -7.10% |
| Pretax Margin | -6.43% |
| Profit Margin | -9.40% |
| EBITDA Margin | -2.92% |
| EBIT Margin | -7.10% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.47% |
| Earnings Yield | -1.56% |
| FCF Yield | -0.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 4.11.
| Altman Z-Score | 4.11 |
| Piotroski F-Score | n/a |